Buparlisib, an oral pan-PI3K inhibitor for the treatment of breast cancer

Elena Geuna, Andrea Milani, Rossella Martinello, Caterina Aversa, Giorgio Valabrega, Maurizio Scaltriti, Filippo Montemurro

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Buparlisib, an oral pan-PI3K inhibitor for the treatment of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences